Loading clinical trials...
Loading clinical trials...
Biweekly Docetaxel (Taxotere®)in Combination With Capecitabine (Xeloda®)as First-Line Treatment in Patients With Advanced Gastric Cancer
Conditions
Interventions
docetaxel and capecitabine
Locations
6
Finland
Kuopio University Hospital
Kuopio, Finland
Oulu Univerity Hospital
Oulu, Finland
Satakunta District Hospital
Pori, Finland
University of Tampere
Tampere, Finland
Department of Oncology and Radiotherapy, turku University Hospital
Turku, Finland
Vaasa Distric Hospital
Vaasa, Finland
Start Date
June 1, 2006
Primary Completion Date
March 1, 2009
Last Updated
April 30, 2008
NCT06885697
NCT06630130
NCT07035587
NCT01649271
NCT02310230
NCT06260150
Lead Sponsor
University of Turku
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions